The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid …

E Brogi - Virchows Archiv, 2022 - Springer
Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of atypical dyscohesive
epithelial cells characterized by loss or functional alteration of E-cadherin-mediated cell …

The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid …

E Brogi - Virchows Archiv: an International Journal of Pathology, 2022 - europepmc.org
Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of atypical dyscohesive
epithelial cells characterized by loss or functional alteration of E-cadherin-mediated cell …

The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid …

E Brogi - Virchows Archiv: European Journal of Pathology, 2022 - search.ebscohost.com
Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of atypical dyscohesive
epithelial cells characterized by loss or functional alteration of E-cadherin-mediated cell …

The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid …

E Brogi - Virchows Archiv: an international journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of atypical dyscohesive
epithelial cells characterized by loss or functional alteration of E-cadherin-mediated cell …

The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid …

E Brogi - Virchows Archiv, 2022 - search.proquest.com
Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of atypical dyscohesive
epithelial cells characterized by loss or functional alteration of E-cadherin-mediated cell …